Skip to main content

Table 1 Demographic and clinical characteristics of IBS-D patients at baseline

From: Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation

 

IBS-D (n = 21)

Variable

 

 Gender (n, %)

 

  Female

5 (23.81)

  Male

16 (76.19)

 Age, year (mean ± SD)

31.38 ± 8.31

 BMI, kg/m2 (mean ± SD)

21.06 ± 2.11

 Duration, year (n, %)

 

  < 1

0 (0)

  1–3

7 (33.33)

  4–10

9 (42.86)

  11–20

3 (14.29)

  > 20

2 (9.52)

 LHBT(n, %)

 

  LHBT (+)

16 (76.19)

  LHBT (−)

5 (23.81)

 Symptoms score (mean ± SD)

 

  Abdominal pain

2.90 ± 1.04

  Abdominal distension

2.00 ± 1.34

  Abdominal discomfort

2.29 ± 1.19

  Diarrhea

3.24 ± 1.37

  Defecatory urgency

3.48 ± 1.03

  Incomplete evacuation

2.71 ± 1.15

  SAS

44.43 ± 6.38

  SDS§

46.19 ± 11.36

  1. LHBT Lactulose hydrogen breath test
  2. SAS Self-Rating Anxiety Scale
  3. §SDS Self-Rating Depression Scale